Central serous chorioretinopathy induced by drugs metabolized by cytochrome P450 3A4

• Autorzy: Morawski K. , Klonowska A. , Kubicka-Trzaska A. , Woron J. , Romanowska-Dixon B.
• Języki publikacji: EN

Abstrakty

EN

Słowa kluczowe

EN

central serous chorioretinopathy; cytochrome P450; CYP3A4 inhibitor; pathogenesis; patient

• Wydawca: -
• Czasopismo: Journal of Physiology and Pharmacology
• Rocznik: 2020
• Tom: 71
• Numer: 2
• Opis fizyczny: p.299-303,ref.

Twórcy

autor

Morawski K.

• Clinic of Ophthalmology and Ocular Oncology, University Hospital, Jagiellonian University Medical College, Krakow, Poland

autor

Klonowska A.

• Clinic of Ophthalmology and Ocular Oncology, University Hospital, Jagiellonian University Medical College, Krakow, Poland

autor

Kubicka-Trzaska A.

• Clinic of Ophthalmology and Ocular Oncology, University Hospital, Jagiellonian University Medical College, Krakow, Poland
• Chair of Ophthalmology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Woron J.

• Chair of Clinical Pharmacology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

autor

Romanowska-Dixon B.

• Clinic of Ophthalmology and Ocular Oncology, University Hospital, Jagiellonian University Medical College, Krakow, Poland
• Chair of Ophthalmology, Faculty of Medicine, Jagiellonian University Medical College, Krakow, Poland

Identyfikatory

DOI

10.26402/jpp.2020.2.15